184 related articles for article (PubMed ID: 32917274)
1. Amyloid-β
Perrone F; Bjerke M; Hens E; Sieben A; Timmers M; De Roeck A; Vandenberghe R; Sleegers K; Martin JJ; De Deyn PP; Engelborghs S; van der Zee J; Van Broeckhoven C; Cacace R;
Alzheimers Res Ther; 2020 Sep; 12(1):108. PubMed ID: 32917274
[TBL] [Abstract][Full Text] [Related]
2. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
Pimenova AA; Goate AM
Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
[TBL] [Abstract][Full Text] [Related]
3. The effects of different familial Alzheimer's disease mutations on APP processing in vivo.
Thordardottir S; Kinhult Ståhlbom A; Almkvist O; Thonberg H; Eriksdotter M; Zetterberg H; Blennow K; Graff C
Alzheimers Res Ther; 2017 Feb; 9(1):9. PubMed ID: 28209190
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
Braggin JE; Bucks SA; Course MM; Smith CL; Sopher B; Osnis L; Shuey KD; Domoto-Reilly K; Caso C; Kinoshita C; Scherpelz KP; Cross C; Grabowski T; Nik SHM; Newman M; Garden GA; Leverenz JB; Tsuang D; Latimer C; Gonzalez-Cuyar LF; Keene CD; Morrison RS; Rhoads K; Wijsman EM; Dorschner MO; Lardelli M; Young JE; Valdmanis PN; Bird TD; Jayadev S
Ann Clin Transl Neurol; 2019 Apr; 6(4):762-777. PubMed ID: 31020001
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
Nudelman KNH; Jackson T; Rumbaugh M; Eloyan A; Abreu M; Dage JL; Snoddy C; Faber KM; Foroud T; Hammers DB; ; Taurone A; Thangarajah M; Aisen P; Beckett L; Kramer J; Koeppe R; Kukull WA; Murray ME; Toga AW; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu JC; Mendez M; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Wolk DA; Carrillo MC; Dickerson BC; Rabinovici GD; Apostolova LG;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S64-S73. PubMed ID: 37801072
[TBL] [Abstract][Full Text] [Related]
6. Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.
Bagyinszky E; Youn YC; An SS; Kim S
Clin Interv Aging; 2016; 11():1467-1488. PubMed ID: 27799753
[TBL] [Abstract][Full Text] [Related]
7. Aβ43 levels determine the onset of pathological amyloid deposition.
Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
[TBL] [Abstract][Full Text] [Related]
8. CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.
Duchateau L; Küҫükali F; De Roeck A; Wittens MMJ; Temmerman J; Weets I; Timmers M; Engelborghs S; Bjerke M; Sleegers K
Alzheimers Res Ther; 2023 Nov; 15(1):195. PubMed ID: 37946268
[TBL] [Abstract][Full Text] [Related]
9. Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.
Damotte V; van der Lee SJ; Chouraki V; Grenier-Boley B; Simino J; Adams H; Tosto G; White C; Terzikhan N; Cruchaga C; Knol MJ; Li S; Schraen S; Grove ML; Satizabal C; Amin N; Berr C; Younkin S; ; Gottesman RF; Buée L; Beiser A; Knopman DS; Uitterlinden A; DeCarli C; Bressler J; DeStefano A; Dartigues JF; Yang Q; Boerwinkle E; Tzourio C; Fornage M; Ikram MA; Amouyel P; de Jager P; Reitz C; Mosley TH; Lambert JC; Seshadri S; van Duijn CM
Alzheimers Dement; 2021 Oct; 17(10):1663-1674. PubMed ID: 34002480
[TBL] [Abstract][Full Text] [Related]
10. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.
Chhatwal JP; Schultz SA; McDade E; Schultz AP; Liu L; Hanseeuw BJ; Joseph-Mathurin N; Feldman R; Fitzpatrick CD; Sparks KP; Levin J; Berman SB; Renton AE; Esposito BT; Fernandez MV; Sung YJ; Lee JH; Klunk WE; Hofmann A; Noble JM; Graff-Radford N; Mori H; Salloway SM; Masters CL; Martins R; Karch CM; Xiong C; Cruchaga C; Perrin RJ; Gordon BA; Benzinger TLS; Fox NC; Schofield PR; Fagan AM; Goate AM; Morris JC; Bateman RJ; Johnson KA; Sperling RA;
Lancet Neurol; 2022 Feb; 21(2):140-152. PubMed ID: 35065037
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.
Galla L; Redolfi N; Pozzan T; Pizzo P; Greotti E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991578
[TBL] [Abstract][Full Text] [Related]
12. Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
Course MM; Gudsnuk K; Keene CD; Bird TD; Jayadev S; Valdmanis PN
Brain; 2023 Feb; 146(2):507-518. PubMed ID: 35949106
[TBL] [Abstract][Full Text] [Related]
13. Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer's Disease.
Ma L; Wang F; Chen S; Wang S; Wang Z; Xia M; Li Y; Ma H; Shang J; Zhang J
Neuromolecular Med; 2024 Mar; 26(1):6. PubMed ID: 38504005
[TBL] [Abstract][Full Text] [Related]
14. Genes associated with Alzheimer's disease: an overview and current status.
Giri M; Zhang M; Lü Y
Clin Interv Aging; 2016; 11():665-81. PubMed ID: 27274215
[TBL] [Abstract][Full Text] [Related]
15. Early-Onset Alzheimer's Disease: What Is Missing in Research?
Ayodele T; Rogaeva E; Kurup JT; Beecham G; Reitz C
Curr Neurol Neurosci Rep; 2021 Jan; 21(2):4. PubMed ID: 33464407
[TBL] [Abstract][Full Text] [Related]
16. Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes.
van Heusden FC; van Nifterick AM; Souza BC; França ASC; Nauta IM; Stam CJ; Scheltens P; Smit AB; Gouw AA; van Kesteren RE
Alzheimers Res Ther; 2023 Aug; 15(1):142. PubMed ID: 37608393
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biological, and imaging features of monogenic Alzheimer's Disease.
Pilotto A; Padovani A; Borroni B
Biomed Res Int; 2013; 2013():689591. PubMed ID: 24377094
[TBL] [Abstract][Full Text] [Related]
18. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
Novotny BC; Fernandez MV; Wang C; Budde JP; Bergmann K; Eteleeb AM; Bradley J; Webster C; Ebl C; Norton J; Gentsch J; Dube U; Wang F; Morris JC; Bateman RJ; Perrin RJ; McDade E; Xiong C; Chhatwal J; ; ; ; Goate A; Farlow M; Schofield P; Chui H; Karch CM; Cruchaga C; Benitez BA; Harari O
Alzheimers Dement; 2023 May; 19(5):1785-1799. PubMed ID: 36251323
[TBL] [Abstract][Full Text] [Related]
20. Genetic aspects of Alzheimer's disease.
Zekanowski C; Religa D; Graff C; Filipek S; Kuźnicki J
Acta Neurobiol Exp (Wars); 2004; 64(1):19-31. PubMed ID: 15190677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
